O-x Synthetic Cannabinoids Research Dashboard
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 35 studies associated with O-x Synthetic Cannabinoids.
Here is a small sampling of O-x Synthetic Cannabinoids studies by title:
- Activation of GPR55 attenuates cognitive impairment, oxidative stress, neuroinflammation, and synaptic dysfunction in a streptozotocin-induced Alzheimer's mouse model
- Pharmacological Activation of GPR55 Improved Cognitive Impairment Induced by Lipopolysaccharide in Mice
- Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966
- A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo
- Stimulation of Atypical Cannabinoid Receptor GPR55 Abolishes the Symptoms of Detrusor Overactivity in Spontaneously Hypertensive Rats
Components of the O-x Synthetic Cannabinoids Research Dashboard
- Top medical conditions associated with O-x Synthetic Cannabinoids
- Proven effects in clinical trials for O-x Synthetic Cannabinoids
- Receptors associated with O-x Synthetic Cannabinoids
- Individual study details for O-x Synthetic Cannabinoids
Ready to become a subscriber? Go to our PRICING page.
Page Quick Links
Select New Cannabinoid
Overview - O-x Synthetic Cannabinoids
Description of O-x Synthetic Cannabinoids
The O-x class of synthetic cannabinoids contains diverse members many of whose effects and binding potential are still subject to ongoing scientific exploration.
Here we focus on one of the better researched members i.e., O-1966.
Other O-related synthetic cannabinoids that show up in the primary studies section include O-1602 (GPR55 agonist), O-1663, O-3223, O-3853.
Other Names:
O-x Synthetic CannabinoidsO-1966 plus other supplier-based synonyms
IUPAC name: 1-[4-(1,1-dimethyl-heptyl)-2,6-dimethoxy-phenyl]-3-methyl-cyclohexanol
Source–PubChem
O-x Synthetic Cannabinoids Properties and Effects
O-1966 may:
- Protective during cerebral ischemia/reperfusion injury (R. Ronca et al., 2015)
- Significant decrease in HIV-1 reverse transcriptase activity (S. Ramirez et al., 2013)
- Neuroprotective in traumatic brain injury (M. Elliott et al., 2011)
- Decrease symptoms of stroke (M. Zhang et al., 2007)
O-x Synthetic Cannabinoids Receptor Binding
Endocannabinoid system (ECS) and O-1966:
- CB2 agonist
Endocannabinoidome (eCBome) and O-1966:
- Mu-opioid receptor binding (Z. Reichenbach et al., 2022)
Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.
